Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Hallucinations (chemically induced) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Half-Life < Hallucinations (chemically induced) < Hallucinations (classification)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000229 (2000) N A Leopold [États-Unis]Risperidone treatment of drug-related psychosis in patients with parkinsonism.
000904 (2002) William G. Ondo [États-Unis] ; Joel K. Levy ; Kevin Dat Vuong ; Christine Hunter ; Joseph Jankovic [États-Unis]Olanzapine treatment for dopaminergic-induced hallucinations.
000947 (2002) H Christopher Hyson [Canada] ; Andrew M. Johnson ; Mandar S. JogSublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.
000957 (2002) Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra ; Robert A. HauserClozapine withdrawal symptoms in a Parkinson's disease patient.
000B07 (2003) Georg Ebersbach [Allemagne]An artist's view of drug-induced hallucinosis.
000C84 (2004) Jorge L. Juncos [États-Unis] ; Vicki J. Roberts ; Marian L. Evatt ; Rita D. Jewart ; Colleen D. Wood ; Larry S. Potter ; Hann-Chang Jou ; Paul P. YeungQuetiapine improves psychotic symptoms and cognition in Parkinson's disease.
001207 (2005) William G. Ondo [États-Unis] ; Ron Tintner ; Kevin Dat Voung ; Dejian Lai ; George RingholzDouble-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease.
001439 (2006) Christopher G. Goetz [États-Unis] ; Joanne Wuu ; Linda Curgian ; Sue LeurgansAge-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.
002361 (2008) Jennifer G. Goldman [États-Unis] ; Christopher G. Goetz ; Melanie Brandabur ; Michelle Sanfilippo ; Glenn T. StebbinsEffects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies.
002949 (1991) M J Steiger ; N P Quinn ; B. Toone ; C D MarsdenOff-period screaming accompanying motor fluctuations in Parkinson's disease.
002C56 (2010) Francisco De Assis Aquino Gondim ; Helida A. Costa ; Tauily C D. Taunay ; Gisele R. De Oliveira ; Jamile Magalhães Ferreira ; Francisco H. RolaTransient amantadine-induced musical hallucinations in a patient with Parkinson's disease.
003C72 (1990) R F Pfeiffer ; J. Kang ; B. Graber ; R. Hofman ; J. WilsonClozapine for psychosis in Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Hallucinations (chemically induced)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Hallucinations (chemically induced)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Hallucinations (chemically induced)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024